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Abstract
Newborn infants are vulnerable to pertussis infections. Although the Advisory
Committee on Immunization Practices (ACIP) recommends that babies begin their diphtheria,
tetanus and acellular pertussis (DTaP) immunization series at two months of age, the minimum
age for administration of the vaccine is six weeks of age (Centers for Disease Control [CDC],
2008). Young infants are at risk for whooping cough infection transmitted from parents, siblings
and care-givers during the pre-vaccination period in the first two months of life, particularly
pertussis transmitted from their mothers. Since the licensure of adult/adolescent formulations of
tetanus, diphtheria and acellular pertussis (Tdap) vaccine in 2005, healthcare providers have been
encouraged to use Tdap vaccine in the family and caregivers of susceptible infants. Vaccinating
the family and close contacts of the baby helps to establish a „protective cocoon‟ of
immunization against pertussis around the child (CDC, 2008). The ACIP guideline on the
prevention of pertussis in post-partum women promotes the use of Tdap vaccine in the period
immediately following delivery in the hospital setting for susceptible mothers (CDC, 2008).
The purpose of this project was to conduct a program evaluation of current immunization
practices, and to assess the feasibility of instituting standing orders for Tdap immunization, in a
birthing hospital. The evaluation was conducted with members of the medical and nursing
obstetrical service in a tertiary care medical center of 783 beds in Western Massachusetts during
the winter of 2009-2010. The project was carried out utilizing program evaluation guidelines
published by the Centers for Disease Control (CDC, 2007). The program evaluation found that
the project hospital met standards for providing immunization in a non-traditional setting and the
evaluation culminated with a recommendation for instituting Tdap immunization on the birthing
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unit. The Capstone experience concluded that the birthing hospital is an apt setting for
immunization standing orders and an ideal partner in addressing the public health issue of
increasing pertussis incidence.
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Introduction
This project centered on a program evaluation of a hospital‟s current practices regarding
pertussis immunization and to assess the feasibility of developing a standing order for Tdap
immunization in the maternity unit of the medical center under study. This paper presents the
mechanisms of transmission of pertussis infection, current immunization recommendations for
pertussis, and the use of standing orders for Tdap immunization among newborn mothers in a
birthing facility. The ultimate goal of the project was to increase the protection of newborn
infants in the battle against this vaccine preventable disease.
Young infants are particularly susceptible to whooping cough infection transmitted from
parents, siblings and caregivers during the period prior to initiation of their vaccination series,
from birth through the first few months of life. The 2005 licensure of Boostrix® and Adacel®
vaccines was hailed as a way to counter waning immunity among adolescent and adult
populations which represents a reservoir of infection and a potential transmission threat to
infants. Health care providers have been encouraged to use Tdap vaccine for immediate and
extended families, as well as caregivers of newborns. This use of Tdap provides an indirect
means of protecting vulnerable infants from pertussis infection, helping to establish a „protective
cocoon‟ of immunization against pertussis around the baby (CDC, 2008a).
A prospective area of application for improving Tdap immunization rates includes
establishing standing orders for Tdap immunization of newborn mothers in birth hospitals. This
program evaluation will seek to determine the feasibility, facilitating factors, and barriers to
implementing standing orders for Tdap immunization in the birth setting. Although various
members of the project site expressed a desire to implement a Tdap program, they also expressed
the difficult in “pulling a program together”. The program evaluation was seen as a way of
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preparing for a Tdap program by identifying current practice, formalizing the process, bringing
together the required parties, documenting a need, exploring the situation and using the report to
actualize a proposal into a bona fide program.
Project Rationale
The implementation of Tdap standing orders in the birth hospital represents a window of
opportunity to immunize the mother of the newborn. The ACIP guideline relates the evidence
and rationale for administering Tdap vaccine to post-partum women (CDC, 2008). Tdap is not
recommended for use in expectant women in any country as the safety and efficacy of Tdap
vaccine has not been demonstrated in pregnant women (CDC, 2008). There is also concern that
Tdap-induced transplacental maternal antibody might have a negative effect on the infant‟s
ability to develop a protective immune response from routine DTaP vaccine administered at the
recommended time (CDC, 2008). Developing a program to administer Tdap vaccine in the
immediate post-partum period represents an advantageous moment in time, not only to protect
susceptible mothers, but also to extend protection to newborn babies.
Standing orders for immunization “enable non-physician personnel such as nurses to
administer vaccinations using an approved protocol without the direct involvement of a
physician”, (Philadelphia Immunization Best Practices, 2009). Evidence shows that standing
orders are an effective means of increasing immunization rates (Briss, 2000). Standing orders as
a preventive tool are “recommended” by the United States Preventive Services Task Force
(USPSTF) in their Guide to Community Preventive Services (Zaza, 2005). The Task Force found
that “Standing orders, when used alone, were effective in increasing vaccine coverage in adults
by approximately fifty-one (51) percentage points” (Zaza, 2005). The Community Guide
evaluated twelve studies that USPSTF utilized to determine the strength of evidence for standing
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orders. One study found that improvements in immunization coverage rates associated with the
use of standing orders continued over a span of five years although most of the studies averaged
about a year.
Intent of Program Evaluation
The intent of this program evaluation was to assess the feasibility of developing a
standing order for Tdap immunization in the maternity unit of the medical center under study.
This was undertaken by evaluating current immunization activities and then evaluating the
possibility of adopting a standing order system for Tdap. The aims of program evaluation,
“stimulating improvements, improving outcomes and translating findings into practice” (CDC,
1999) were put into application using the Framework for Program Evaluation in Public Health
Practice. The Framework is a tool that promotes a systematic method “to improve and account
for public health actions involving procedures that are useful, feasible, ethical, and accurate”
(CDC, 1999). CDC has an on-going program to assist in developing evaluation programs as an
overall focus on health improvement but specifically in developing strong partnerships that
“allow partners to achieve common goals” (CDC, 1999). This project explored aspects of
partnership of a community hospital and the state health department. CDC has stated that
program evaluation is necessary for guiding public health interventions which include science as
a basis for decision-making, expanding the quest for social equity, performing effectively as a
service agency, making efforts outcome oriented, and being accountable” (CDC, 1999). The
intent of this project sought to address improving access to immunization services and increasing
immunization coverage in a specific cohort.
Theoretical Foundation
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The theoretical basis for implementing Tdap immunization standing orders in a birthing
facility comports with Lewin‟s Theory of the stages of change (Dale & Sorenson, 1975).
Hospitals, for the most part, operate under the premise of medical orders written specifically for
individual patients. Institution of standing orders would require an „unfreezing‟ (the first stage of
change) of the traditional medical model. The second stage – „changing‟, an area ripe for
nursing leadership, would entail composing standing orders, having them reviewed and accepted
by the policy making committees of the facility and establishing the capability to administer
vaccine in the maternity unit. Under Lewin‟s theory, „restraining forces‟ would include a
reluctance by physicians to institute standing orders for immunization by nursing staff or the
non-recognition by providers of the extent of pertussis morbidity. Lewin‟s concept of the third
stage of change – „refreezing‟, would take place when the standing order for Tdap becomes
widely accepted as the new standard of practice within maternity units.
Change Theory applied to public health practice
A study evaluating inpatient standing orders for influenza immunization found that the
main barrier to immunization in the hospital was the requirement for an individual order; “most
of the medical staff did not view vaccination as a priority or were concerned that vaccination
might „complicate‟ the patient‟s course in hospital” (Lawson, Baker, Au, & McElhaney, 2000).
Standing orders can decrease restraining forces by facilitating the process for nurses to
administer vaccine, alleviating the need for individual orders by attendant physicians.
A University of Pittsburgh Medical Center study found that inpatient pneumococcal
(PPV23) immunization rates ranged from 15 – 30% prior to the development of a hospital-based
standing orders program. “The primary reason for lower than expected immunization rates was
the failure of physicians to sign pre-printed orders on the chart” (Sokos, et al, 2007). A multi-
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disciplinary workgroup in which nurses and pharmacists played key roles, created a successful
Standing Order Protocol (SOP) for PPV23 immunization. Dramatic increases were seen in
PPV23 immunization after the institution of an SOP, ranging from 65 – 87% (Sokos, et al, 2007).
The Pittsburgh facility subsequently set up a similar SOP for in-patient influenza vaccination.
Another aspect of the change required for Tdap SOP‟s to be successful is for nursing
personnel to feel empowered in assessing patients for immunization through screening and to use
the SOP to act independently in vaccinating new mothers before discharge. Computer assisted
nursing standing orders improved immunization rates more than physician reminders in a study
comparing the two options (Dexter, Perkins, Maharry, Jones & McDonald, 2004). The „need to
attend to more pressing medical issues‟ and „physician oversight‟ in generating vaccination
orders were cited as reasons for low in-patient pneumococcal vaccination in another study on this
topic (Nowalk, et al, 2003).
Rubenstein & Pugh (2006) also reference the tenets of change theory in promoting
organizational change. They state that there is a quality chasm between what is known from
research to be best practice, and the implementation of those findings. They relate that
implementation science “consists of a body of knowledge on methods to promote the systematic
uptake of new or underused findings into the usual activities of healthcare organizations”
(Rubenstein & Pugh, 2006). In order for organizational change to occur, such as adopting
standing orders in a birthing facility, a culture change may also need to occur. Vaccination was
traditionally viewed as “clinic medicine”; over time, wider availability of vaccination has been
realized through the advent of immunization clinics held in pharmacies and grocery stores;
through „vote and vaccinate‟ campaigns and even in „drive-through‟ immunization campaigns.
The culture change inherent in these efforts lessens the mystique of immunization and
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demonstrates both the ability to reach larger cohorts and the ability for nurses to be the agents of
change, and promotes the overall safety of immunization in “ordinary” settings.
The last stage of change, „refreezing‟ represents the adaptation of involved parties to
adopt the new condition – the standing order for immunization in a hospital setting. Refreezing
has occurred for inpatient standing order protocols for influenza and pneumonia vaccines with
the assistance of oversight agencies. The Center for Medicare and Medicaid Services (CMS)
changed its Conditions of Participation in 2002 to remove requirements for individual patient
orders for both influenza and pneumococcal immunization in provider‟s offices, long term care
facilities, and home health agencies (Nowalk, et al, 2003). CMS continues to encourage
immunization by annually increasing reimbursement rates for immunization administration.
A study was designed that based the implementation of an inpatient standing order
program for pneumococcal immunization program on registered nurses in assessing and
administering vaccine to patients. In the ninety days after implementation, the hospital program
was successful in raising pneumococcal immunization rates from 13% to 26% (Eckrode, Church,
& English, 2006). In 2005, a New Jersey review found that the prevalence and trend for
hospital-based standing order protocols was increasing over time (Pentakota & Halperin, 2007).
Referring to influenza and pneumococcal protocols, Pentakota and Halperin concluded that given
the morbidity and mortality associated with those diseases and the issues of impediments to
vaccination for adults, the role of standing order protocols deserved substantially more attention
(Pentakota & Halperin, 2007).
It is important to take advantage of every healthcare encounter to ensure adults are up-todate with their recommended vaccinations. Hospitals are generally thought of in terms of
providing acute and sometimes chronic patient care and are not usually considered to be public
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health agencies. In contrast, „immunization‟ is frequently proclaimed the quintessential example
of preventive care. The core functions of public health are assessment, policy development and
assurance. One of the facets of assurance is linking people to needed personal health care
services (Aday, 2005). Using the hospital setting for immunization links mothers and infants
with protection against pertussis through in-hospital Tdap immunization of the new mother. In
this sense, the hospital is defined as a public health resource in decreasing susceptibility to
whooping cough in mothers thereby extending protection to their babies. A 2008 article
describing the provision of Tdap vaccine to parents of high-risk infants in a neonatal intensive
care unit found the program to be an effective means of increasing immunization rates in parents
of NICU patients. Importantly, the study concluded that using the hospital setting as an
opportunity for immunization had the potential to mitigate a public health problem (Dylag, &
Shah, 2008).
Change theory aptly applies to the problem of creating a protective cocoon of pertussis
immunization to surround young infants. Perceptions of the disease burden and severity of
illness on the part of obstetrical providers may require a change in knowledge, developing an
expectation for immunization in all health care settings – including birthing hospitals - requires a
change in attitude and instituting standing orders rather that individual provider orders in the
hospital setting requires a change in practice.

Review of the Literature
Study Significance
Pertussis, commonly known as whooping cough, is an acute infectious disease caused by
the Bordetella pertussis bacterium. The organism was isolated in 1906 and the first pertussis
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vaccine was made available in the early 1940‟s (CDC, 2009). Prior to the licensure of a vaccine,
approximately 270,000 cases were reported annually with some 10,000 deaths (Plotkin,
Orenstein, & Offit, 2008). Cases declined precipitously after the introduction of a vaccine,
especially after the inclusion of pertussis-containing vaccine to school entry requirements in
many states. The lowest point recorded for pertussis incidence occurred in 1976 when only
about 1,000 cases were reported through state and national surveillance systems (Plotkin,
Orenstein, & Offit, 2008). Since that time, unlike other vaccine-preventable diseases, pertussis
cases have continued to increase, particularly among adolescents and adults. Over 25,000 cases
were identified in 2004, the highest number reported since 1959 (Plotkin, Orenstein, & Offit,
2008). Recent reports demonstrate the threat that circulating pertussis poses to infants too young
to have received the first three doses of pertussis-containing vaccine. Between 2000 and 2004,
an average of almost 2,500 cases annually were reported among infants less than a year of age,
with 63% requiring hospitalization (Plotkin, Orenstein, & Offit, 2008). In 2005-2006, the
incidence of pertussis in infants less than six months of age was 111 cases per 100,000
population; for infants six to eleven months of age, the incidence declined to 19 cases per
100,000 (CDC, 2008a). The majority of infant deaths have occurred among unvaccinated infants.
There were 40 pertussis-related deaths in 2005 and 16 in 2006. Of these deaths, 39 (98%)
occurred in infants during 2005 and 14 (88%) in 2006 (CDC, 2008a). At increased risk for
pertussis mortality are Latino infants, infants born at less than 37 weeks gestation and babies
who are born at low birth weights (CDC, 2008a). The development and maturity of the infants‟
respiratory system in premature and low birth with babies has an obvious impact on their ability
to cope with an insult to the lungs, such as in whooping cough, however the reason for greater
risk among Latino infants remains unclear.
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Evidence shows that infants are at greatest risk for infection from family members and
close contacts. Household members, relatives living in the infants‟ home and care givers who are
susceptible to pertussis may become infected and potentially transmit infection to the child
(Gerbie & Tan, 2009). The most frequent source of pertussis infection in infants was found to be
the baby‟s mother, with transmission likely due to the close and prolonged contact between
mother and child, especially during feeding times (Wendelboe, et al. 2007).
Pertussis disease remains a major health problem, primarily due to waning immunity in
those previously vaccinated, the lack of a safe and efficacious vaccine for adults – prior to 2005,
missed diagnosis of cases by providers, and the prolonged length of time for uptake of new
vaccine biologics to become widely dispersed in communities. Professional organizations have
developed recommendations for a “cocooning strategy” for pertussis immunization, figuratively
wrapping the infant within a protective cushion of immunization. The strategy counsels that
Tdap vaccine should be administered to parents, siblings, grandparents, care-givers, and health
care workers in contact with newborn babies. The Advisory Committee on Immunization
Practices (ACIP) and the American Congress of Obstetricians and Gynecologists (ACOG) are
endorsing Tdap immunization of new mothers in the birthing facility as the Standard of Care
(Appendix A).
Standing Orders
In 2000, ACIP published recommendations for standing order programs as a method of
increasing immunization rates among adults (Centers for Disease Control, 2000). The
Committee encouraged the introduction of standing orders in non-traditional areas such as
outpatient and inpatient hospital settings, managed-care organizations, assisted living facilities,
correctional facilities, pharmacies, adult workplaces, and home-health care agencies (CDC,
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2000). ACIP also recommends that Tdap vaccine be administered to adolescents and adults who
have contact with young children and to women of child bearing age during routine preconception health care visits or during the immediate post-partum period (CDC, 2008). Thus
nurses caring for patients in birthing facilities are uniquely positioned to provide expanded
access to pertussis protection via the implementation of standing orders for Tdap immunization
in the post-partum hospital setting.
In Massachusetts, the Board of Registration in Nursing (BORN), under the Executive
Office of Health and Human Services (EOHHS) regulates the use of “Standing Order Protocols”
(SOPs) for administration of vaccines as an aspect of nursing practice. In 1998, the BORN
issued a regulatory interpretation advising that licensed nursing professionals in the
Commonwealth may administer immunizing agents under standing order protocols (Appendix
B). Under the provisions of standing orders the nurse must undertake the following steps:


verify that the standing orders are signed by a duly authorized prescriber;



be educated in proper storage and handling of vaccine biologics, administration;
contraindications, adverse event reporting, and documentation.



comply with federal and state laws in regard to record keeping;



provide client education on the risks and benefits of accepting or refusing the immunizing
agent;



document a process of informed consent, reflective of the required educational materials;



complete an assessment of the client‟s condition in relation to history of allergies prior to
immunization;



be knowledgeable about access to emergency services, devices and techniques in the
event of adverse reactions and;
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obtain parental consent in the case of vaccine administration to minors, in compliance
with federal, state and local statutes.

Current clinical problem
Issel points out that when data are collected at the aggregate level, for example, in a preintervention environment, this helps to establish baseline data (Issel, 2009). The National
Immunization Survey (NIS), the Behavioral Risk Factor Surveillance Survey (BRFSS), and the
National Health Interview Survey (NHIS) have added Tdap coverage to their surveillance
assessments of immunization status. Since Tdap vaccine for adults was only recently licensed
(i.e. 2005), many facilities, including most birthing facilities, are not yet in the habit of gathering
Tdap immunization information.
MDPH will conduct the second portion of a statewide CDC birth hospital survey this
spring, including audits of birth records from 2008 deliveries. The first part of the birth hospital
survey was conducted last year that consisted of policy reviews within the 48 birth hospitals and
2 free-standing birthing facilities. The initial survey in 2009 was designed to elicit information
regarding the implementation of ACIP recommendations for the birth dose of hepatitis B vaccine
and post-exposure prophylaxis for babies born to HBsAg+ mothers. It also queried facilities on
the use of standing orders for influenza and Tdap immunization. Of the fifty birthing facilities in
the Commonwealth, eleven of those sites report having a policy for Tdap immunization in place
(Mary Conant, MDPH Deputy Immunization Program manager, personal communication,
August 3, 2009). The current record review will in part assess which facilities are routinely
screening for and documenting Tdap immunization status of women presenting for delivery in
the hospital setting providing baseline data for the state immunization program.
Barriers to Immunization

Standing Orders for Tdap Immunization

17

A recent review of adolescent and adult immunization issues in Massachusetts found
significant obstacles to vaccination in these populations. In adolescents, several factors,
primarily financial in nature, were found to present barriers to immunization. Limited
availability of state supplied (“free”) vaccines and lack of comprehensive insurance coverage for
immunization were common problems. In many instances where coverage was available,
inadequate reimbursement to the provider for the cost of administering vaccines and a lack of
reimbursement for vaccines administered outside of the primary medical home were
disincentives to immunization. A lack of measurement of adolescent vaccination coverage at the
provider level, and the current lack of K-12 school requirements for Tdap were cited as
challenges to increasing immunization in this age group (Lazorik, Hoffman, & Fuchs, 2009).
For adults, misconceptions among providers about the burden of pertussis disease, hesitancy
related to vaccine safety on the part of patients and providers, and a lack of comprehensive
coverage for immunization are all factors adversely affecting the provision of Tdap (and other)
vaccines. Missed opportunities to assess immunization status and administer immunizations in
all health care settings were found to be problematic in both adolescent and adult cohorts
(Lazorik, Hoffman, & Fuchs, 2009). This is exacerbated in the some areas of the state which are
federally designated medically underserved areas (MUA), further limiting opportunities for
adults to receive medical care and preventive services.
Access to Immunization
A clinical review of pertussis infection in the United States concluded that Tdap
immunization could have a substantial positive impact on pertussis morbidity and mortality, if
vaccination was widely administered (Brooks, & Clover, 2006). A systematic review of
population-based interventions to improve vaccination coverage found that the positive effects of
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immunization standing orders had been demonstrated in a range of settings including private
practices, community hospitals, and academic clinical organizations (Shefer, et al, 1999). Studies
have demonstrated increased vaccination rates for influenza and pneumococcal disease through
the use of standing order programs (Dexter, Perkins, Maharry, Jones, & McDonald, 2004); one
study also found that the increases in immunization rates were sustainable over a ten-year period
(Nichols, 1998).
Even prior to the licensure of Tdap vaccine, it had been suggested that a possible
approach to expanding access to adult immunizations was to increase the number of sites where
patients could obtain needed vaccines (Bergus, Ernst, & Sorofman, 2001). Subsequent to the
introduction of Tdap vaccine, in a monograph on the implementation of immunization best
practices for special populations, a case study summarized that initiatives for in-patient standing
orders for post-partum immunization of newborn mothers had the potential to significantly
benefit both mothers and infants by reducing the incidence of pertussis infection (Steele, 2008).
Using birthing facilities as a location to implement standing orders for Tdap vaccine
would improve access to the immunization for new mothers. Immunizing post-partum women
will also raise awareness of the need for immunization within the family. This may lead to wider
uptake of the vaccine which would help to build community or herd immunity. This would
ultimately lead to a favorable impact on the prevalence of pertussis morbidity.
Vaccination is increasingly becoming a regular component of services in the hospital
setting as evidenced by the more recent implementation of systems to assess for influenza and
pneumococcal vaccination during acute care stays. Traditionally, new mothers have been
assessed for rubella immunity, with MMR vaccine being routinely administered to susceptible
women. Universal Hepatitis B immunization of newborns has also been in place for nearly two
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decades. Assessing and immunizing against pertussis at the hospitals birthing unit may be
modeled after protocols for influenza, pneumococcal, hepatitis and MMR vaccines. Making
Tdap vaccine available in the birthing facilities would level the playing field of access to
immunization for all new mothers including those who have adequate prenatal care and those
who do not.
Vaccination of Adults
The nation has a long history of providing immunizations to its children including some
of the first legislative efforts to make vaccine available dating back to the provision of polio
vaccine in the 1950‟s. As recounted in Poor People‟s Medicine (Engel, 2006) health legislation,
including that for immunization, evolved over time into a hodgepodge of laws and regulations,
often starting with “deserving” groups such as children and later expanding to provide benefits to
other “at risk” populations. In more recent times, legislation has funded the federal Vaccines for
Children (VFC) entitlement program; there is no such corresponding program to fund vaccines
for adults. Funding for adult vaccines such as Tdap is subject to the adoption of a new vaccine
for coverage by the individual state Medicaid system or by third-party payers. Since there is no
national policy for adult immunization or corresponding legislation, the availability and
provision of vaccines to adults has also resulted in a mixture of funding coverage and services as
evidenced by our corresponding survey of Tdap coverage by Massachusetts health insurance
plans. Some insurers provide full coverage for immunizations, some afford partial coverage
(resulting in a cohort of „under-insured‟ adults) and some provide no coverage for vaccines. As a
consequence, some adult providers do not make vaccination services available in their offices;
this is often a problem with newer vaccines such as Tdap.
Financial Impact
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The economic burden of pertussis infection is estimated to be substantial with direct costs
including the need for hospitalization to treat pertussis-related complications. One study found
that costs for hospitalization in children under 24 months of age were projected to be
approximately $3,000 per case escalating to about $6,000 for treatment of pertussis related
encephalopathy (Greenberg & Caro, 2005). Societal costs of morbidity for adults (≥18 years of
age) with confirmed pertussis were found to be $773 with a mean of $326 for medical costs and
an additional $447 for non-medical costs (Lee, et al, 2004). Medical costs in that study included
physician visits, chest radiography, laboratory tests such as culture, serology and PCR, and the
cost of antibiotics to treat the infection. Non-medical expenses included the costs of associated
child-care, transportation, and OTC preparations (Lee, et al, 2004). Since pertussis cough
symptoms may present similarly to other cough and respiratory illnesses, patients may make up
to two or three trips to a clinician for an accurate diagnosis (DeSerres, et al., 2000). In Lee‟s
study, non-medical costs represented 58% of the total cost burden in adults. If the cost of
antibiotics to treat contacts were included, the societal cost could run as much as $1952 per case,
given an average of 4.3 contacts per case (Lee, et al, 2004).
In a paper describing the cost of nosocomial pertussis in an outbreak amongst health care
workers in a tertiary health care facility, the total measured cost was $81,382 associated with
exposure to one confirmed case of pertussis in an infant (Calugar, Ortega-Sanchez, & Tiwari, et
al, 2005). Seventeen symptomatic cases among health care workers and some 307 contacts of
those HCWs required antibiotic prophylaxis. The contacts included other patients, household
members, and students. The largest direct cost was for laboratory testing and surveillance
activities designed to contain the outbreak. The largest indirect costs resulted from furloughs of
infected workers (Calugar, Ortega-Sanchez, & Tiwari, et al, 2005).
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The Program Evaluation
The Centers for Disease Control and Prevention has provided a number of documents to
guide program evaluations. This capstone experience utilized the Framework for Program
Evaluation in Public Health (CDC, 1999) and adapted elements of the Guide to Immunization
Program Evaluation for Grantees (CDC, 2007). Both the Framework and the Grantee guide
begin by outlining the steps of program evaluation listed in Table 1 and the progression of
evaluation steps as depicted in Appendix D.
Program evaluation is a systematic method of evaluation. It is a tool that can assist in
promoting change when adjustments or modifications to programs are necessary or to support
the introduction of a new course of action. Program evaluation summarizes the essential
elements of the program, provides structure to the assessment, and incorporates the use of
standards for appraisal. The steps of change - unfreezing, changing and refreezing – may be
thoughts to mesh with the steps of program evaluation. For example, unfreezing may acquaint
with engaging stakeholders and program description, changing may be aligned with gathering
the evidence and justifying conclusions during the evaluation and refreezing may be seen to
happen when lessons from the program evaluation are shared and used.
Table 1. CDC’s Framework for Program Evaluation Steps.
Step

Actions

1

Engaging stakeholders

2

Describing the program

3

Focusing the evaluation design

4

Gathering credible evidence
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Justifying conclusions
Ensuring use and share lessons

6
learned

The Program Evaluation Site
The program evaluation site is best described as an academic, research, and teaching
hospital serving as a campus for a large medical school. It is a Level 1 trauma center and is
designated as a Magnet hospital for nursing excellence by the American Nurses Credentialing
Center (ANCC). The medical center houses 659 beds in the flagship facility with some 57
bassinets. It provided for approximately 46,000 patient stays and welcomed about 4500 new
infants last year. It is employer to almost 10,000 employees. The hospital was chosen for the
size of its birthing center, its national reputation as one of the Top 100 Hospitals in the Nation,
and its promotion of quality of care and recognition of the importance of nursing in the
healthcare arena.
Engaging stakeholders/ Unfreezing
The initial process, engaging stakeholders at the study site began with identifying key
participants for the Tdap immunization project. These individuals included the Director of
Maternal-Fetal Medicine, the Clinical Coordinator of Labor, Delivery, Recovery and Postpartum units, the Nursing Director of Women‟s and Infant‟s Services, and the Assistant Director
of Pharmacy. These team members satisfied the tenets of the framework seeking to involve those
who would be critical to program operations and the primary users of the evaluation. At the
initial meetings, the role of each person in the evaluation process was identified in Table 2.
Table 2. Evaluation Team Roles and Responsibilities.
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Role

Responsibility

Director of Maternal-Fetal

Oversee the program

Medicine

evaluation
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Main contact for technical
Clinical Coordinator of LDRP

aspects of the program
evaluation.
Identify and coordinate

Nursing Director of Women
interviews with additional
and Infants Services
personnel
Assistant Director of

Coordinate aspects relate to

Pharmacy

product provision

Although the Medical Director represented the ultimate decision maker for the
implementation of Tdap standing orders, these participants identified other relevant stakeholders
to the process -implementers, physician participants, and partners - for developing an
immunization program.
Describing the Program/ Unfreezing
The second step in the program evaluation is to describe the project. The overall goal of
the project was to determine the feasibility of implementing a post-partum Tdap immunization
order within the birthing unit of the Medical Center under study; the primary goal and objectives
for implementing Tdap immunization orders are shown in Table 3.
Table 3. Describing the aims of the project.
Goal

Provide Tdap vaccine in the maternity unit
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1. Institute assessment of Tdap coverage for pregnant women as part of prenatal
screening.
Objectives 2. Develop a program for Tdap immunization before discharge.
3. Undertake educational programs for: obstetricians, OB residents, nurse
midwives, nursing staff, mothers & families

CDC‟s Evaluation Framework suggests that a program description include: the need,
expected effects, activities, resources and stage of development, and context of the program,
concluding with a summary of the elements into a logic model. The hospital's mission is “to
improve the health of the people in communities every day, with quality and compassion”. In
keeping with that mission, implementing standing orders for Tdap vaccine utilizes the window of
opportunity to immunize women while they are in the birth setting. It levels the playing field of
access, utilizes protocols already in place for influenza, rubella, and hepatitis vaccinations, and
occurs as medical centers across the nation begin to implement the protocol as the standard of
care promoted by nationally recognized authorities. The logic model, in Appendix E, developed
over the course of the evaluation lists inputs to the program, activities, measurable outputs, and
short term, intermediate and long term outcomes. Inputs to the logic model are the elements of
staff and materials that would be necessary to undertake the program, activities include the
actions taken in preparation and the behaviors of the program, the term output denotes the
measurable „harvest‟ of the activities, short term outcomes indicate the immediate product,
intermediate outcomes are the further results of the program, long term outcomes are the ultimate
goals of the project.
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Table 4 displays the issues related to administration of Tdap vaccine that were identified
by the program evaluation questions. The questions developed during the initial stage of
meetings, helped to center specific aspects of the issue that will be weighed and hopefully help to
concentrate the findings into a consensus of recommendations. The answers to the program
evaluation questions were elicited during interviews with maternity nurses, infection control
staff, pharmacy personnel, nurse midwives, and from experts consulted for the external review
panel.
Table 4. Guiding the focus of the program evaluation.
What problem does this program

lack of pertussis immunization

component address?
myriad issues: lack of immunization
service from adult providers, lack of adult
What causes the problem?

primary care providers, misunderstanding
of the burden of disease

reservoir of pertussis infection, propensity
What are the consequences of the problem?
for transmission to newborn infants
increased morbidity and severity among
What is the magnitude of the problem?
infants
increasing pertussis incidence over the last
What changes or trends have occurred?
two decades
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There is a gap in uptake of pertussis-containing vaccine in adult cohorts and some
adolescents, especially among women of child-bearing age. Multiple issues have been identified
as problems in adult vaccination programs, such as 1) limited availability of state supplied
(“free”) vaccines; 2) lack of comprehensive insurance coverage for immunization; 3) inadequate
reimbursement to the provider for the cost of administering vaccines; 4) misconceptions among
providers about the burden of pertussis disease; 5) hesitancy related to vaccine safety on the part
of patients and providers; 6) missed opportunities to administer immunizations in all health care
settings (Lazorik, Hoffman, & Fuchs, 2009).. These issues were found to be problematic in both
adolescent and adult cohorts (Lazorik, Hoffman, & Fuchs, 2009). The consequence of low
pertussis-containing vaccine coverage is the pool of infection existing in the community
permitting transmission to susceptible infants. The magnitude of the problem is demonstrated by
the impact of morbidity and mortality on newborns with the trend for pertussis increasing over
the past three decades. Other issues related to this population were identified during the
evaluation process. For example, many women of child –bearing age are considered to be in the
prime of health and thus do not seek out regular health care visits with health care providers.
Once a woman becomes pregnant, it is has been stated that the obstetrician becomes the defacto
primary health care provider. Another issue pertinent to areas that are considered to be
“medically-underserved areas” (MUA), is that there is a lack of primary providers. The local
community health centers (CHCs) report that patients may encounter waits of up to several
months for routine health care visits, and often have little choice of providers who are
„accepting‟ new patients. These factors coupled with an infectious disease on the rise, creates a
“perfect storm” that threatens the health of newborn infants.
Focusing the evaluation design
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“Program evaluation remains more an art than a science”, (Burns & Grove, 2005). There
are two basic designs of program evaluation, those seeking to answer process questions and
those seeking to define outcomes. Thus, this program evaluation sought to examine in-hospital
immunization and the feasibility of making Tdap vaccine available in the women‟s unit. The
CDC guide presented suggested standards for focusing the program evaluation: utility and
feasibility. In term of utility, Table 5 served as a worksheet identifying who will use the
evaluation findings; how they will be used; and what they need to learn from the evaluation,
(CDC, 2007). With regard to feasibility, the evaluation solicited information regarding
identification of the resources necessary to carry out the program; What new educational
materials might be needed?; What community partners (e.g. outpatient clinic staff, vaccine
representatives) would be necessary to engage?; Will additional staff training be necessary?; Will
it be necessary to write additional policies?; and What outreach efforts will be needed?
Table 5. Focusing the Evaluation Worksheet.
What do they need to learn from
Who will use the findings?

How will the findings be used?
the evaluation?

Obstetrical staff

Does the program staff have the

Justify the need for such a

OB Residents

requisite knowledge to

program?

Nurse Midwives

implement the program?

Identify a timeline for program

Nursing staff

What are the funding issues

activities

related to the program?

Identify midcourse alterations

What barriers exist to

to the program.

implementing the program?

Modify/identify additional

How will the program measure

program needs (e.g. future

Pre-natal clinic staff
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performance?

educational needs)

What outreach/educational

Advocate/promote the program

efforts will be required to

component in the community

implement the program?

The program evaluation design consisted of individual interviews, group dialogues,
attendance at regularly schedule meetings, review of documents and policies, and the use of an
expert review panel. The project began with an initial identification of participants, but was an
iterative process in that as the project progressed, additional participants and pertinent meetings
were identified. During each meeting and interview, roles of the participants were identified. At
the end of each meeting tasks were identified and responsibilities assigned to members. The
course of the in-hospital program evaluation included clinical nurse managers from maternity
and neonatal units, medical and nursing administration from obstetrics, obstetrical nursing
informatics liaison, hospital infection preventionists, quality improvement staff, pediatric
infectious disease physicians, the pharmacy department, the emergency department director,
financial managers, and ethics committee members.
The purpose of the interviews and meetings was to gain insight into the perspective for an
identified need, the abilities of each individual member or group of members, and the necessities
for a Tdap order to be implemented. At each step barriers and facilitating factors were brought
up and discussion included measuring the fundamental effect of the program. Discussion also
included the aspect of practice change necessary to incorporate a new standard of care to refine
services already in place.
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The interviews found that there were three main areas of concern for implementing a new
treatment: education, logistics of Tdap immunization, and cost. Educational needs were
identified for the various stakeholders to the program: the obstetricians, the OB resident staff,
nurse mid-wives, the nursing staff and ultimately the patients. Logistical concerns included
questions over contraindications for Tdap vaccine, the issue of simultaneous administration with
other products such as Rhogam®, informed consent to vaccination and documenting the
immunization in the EMR. The issue of cost was of great concern. Discussion centered on
potential reimbursement for vaccination from third party payers and the availability of funding
for vaccination in the hospital setting.
Gathering credible evidence/ Changing
Evidence in this program evaluation took many forms. Standards for conducting adult
immunization programs in non-traditional settings, listed in Appendix F, were utilized both for
the program evaluation and to determine if any gap existed (CDC, 2000). National and state
statistics for Tdap vaccine coverage were collected, as was data on the number of births at the
site, the reported reimbursement coverage for Tdap immunization by Massachusetts health care
plans and the availability of state supplied (“free”) vaccine.
The Centers for Disease Control requires the all vaccinees be provided information on the
risks and benefits of vaccination. To facilitate and standardize the informational process, CDC
develops educational material in the form of Vaccine Information Statements (VIS forms) that
are made electronically available at the CDC website (http://www.cdc.gov/vaccines/pubs/vis/visdownloads.htm) and the Immunization Action Coalition website (www.immunize.org). The VIS
forms satisfy federal and state (Commonwealth of Massachusetts) educational requirements
under “Duty to Warn” provisions. There are no federal or state “informed consent” or signature
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requirements for vaccine administration. The development of VIS forms by the CDC ensures
that information in current, the Tdap VIS in Appendix G was most recently updated in
November of 2008, and that they are culturally and linguistically appropriate. VIS forms are
available in multiple languages and are formatted for a fifth grade reading level. VIS formats are
also available in an audio format for ease of technology use. The implementation of this
standard was already familiar to the nursing staff at the facility due to the long standing universal
provision of hepatitis B vaccine to newborns, the provision of MMR vaccine to rubellasusceptible women, and the more recent hospital protocols making influenza and pneumococcal
vaccines available to hospitalized patients. In the study hospital, Maternity nurses are well
versed in obtaining current VIS forms and forms in various foreign languages and the provisions
for educating patients by reviewing VIS form information. This is most commonly done for the
birth dose of hepatitis B vaccine for newborns but was also carried out with regularity for H1N1
influenza vaccination in recent months.
At the facility, the maintenance of biologic supplies is overseen by the Pharmacy
Department. The vaccine platform in this hospital is held by the GlaxoSmithKline (GSK)
vaccine manufacturer. During the program evaluation, discussions were facilitated between the
pharmacy department and the local GlaxoSmithKline (GSK) vaccine representative. Plans for a
prospective Tdap initiative at the site were conveyed to the two national distribution centers
McKesson and Cardinal, via the GSK representative, (John Crowley, personal communication,
February 11, 2010). The effect of the notification is that the medical center is now able to order
additional doses of Tdap vaccine as needed without potential delays within the „just-in-time‟
supply chain.
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The Pharmacy department has policies in place for maintaining the proper storage
environment for vaccine biologics to maintain their potency and effectiveness; for inactivated
vaccines, this generally means refrigerated storage between 2 – 8 ° C. The hospital currently
maintains supplies of a number of vaccines – hepatitis B, varicella, influenza vaccine,
pneumococcal, MMR, Td and Tdap. To ensure that the cold chain in maintained, the study
hospital requires nursing units that provide vaccines record temperatures twice a day as per
federal guidelines for compliance with vaccine storage practices and the various manufacturer
provisions listed in the individual package inserts of vaccine products. The proper handling of
Tdap vaccine, while a new addition to the biologics offered within the nursing unit, mimics the
storage provisions of other inactivated vaccines such influenza and pneumococcal vaccine,
requiring refrigerated storage (as opposed to frozen storage) which were utilized throughout the
flu season and the on-going provisions for hepatitis B and MMR vaccines.
Standards require obtaining an immunization history from the client prior to
immunization. The ideal situation would be one where every client was fully aware of their
immunization status and in possession of immunization records. This is often not the case with
adults in general and not in the study hospital. Many are unaware of their own vaccination status
and fewer carry adult immunization records. One perceived barrier identified during this
program evaluation is the fact the state of Massachusetts does not have an immunization registry.
Legislation is pending within the legislature of the Commonwealth that addresses funding of an
immunization registry (see discussion under Health Plan Survey). ACIP recommendations state
Td vaccine boosters are usually recommended every ten years and that a shorter interval of five
years is utilized for wound prophylaxis (CDC, 2008). ACIP also recommends that with respect
to pertussis protection, intervals of five years from the last tetanus booster, lessens the potential
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for localized reactions such as redness or swelling after vaccine administration. Importantly,
ACIP states that for post-partum mothers or others having contact with young infants, an interval
of two years or less since the last Td booster, be considered. Educational efforts with all cohorts
at this facility, obstetrical residents, nurse-midwives and nurses included discussion of the
timeframe of licensure of Tdap vaccine (i.e. 2005) and the interval since a patient‟s last Td
immunization. It is hoped that when discussing whooping cough immunization in a relatively
young relatively healthy population, that clients may have some awareness of whether or not
they received a vaccination against tetanus within the last five years. In particular, if a client
expresses that they had a tetanus booster seven years ago, for example, the provider can feel
somewhat certain that the vaccine was the pre-licensure Td product. More questions would arise
if the client stated that they had been vaccinated in the most recent five year period. Ultimately,
ACIP advises that in the absence of documentation, the benefit of pertussis protection outweighs
the smaller risk of vaccine side effects (CDC, 2008 & 2000) and that vaccine is recommended.
Recommendations for best practice would include promoting awareness of adult immunization
through the provision of adult immunization cards documenting vaccine administration dates
similar to the “Blue Book” of infant immunization. This hospital does not routinely provide for
documentation of adult immunizations provided in the facility. Instituting this practice would
improve communication between the acute care setting and the medical home.
In general, assessment of the vaccinee recipient is conducted by the health care provider
who will administer the vaccine, with the criteria for immunization set by the provider. In order
to implement Tdap immunization in the birthing unit of this facility, a nursing policy for
administration of the vaccine would need to be developed. Nursing policies typically set out the
criteria for immunization which would include the true contraindications and precautions
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pertinent to the vaccine. While there is no policy specifically for Tdap currently in the study
hospital, there are policies for rubella and varicella administration and one of those could be
easily adapted for Tdap vaccine administration. The educational effort for the nurses would need
to include identifying misconceptions to vaccine administration and mistaken beliefs about Tdap
vaccine which would provide strength to the nursing assessment prior to immunization
All immunizations in the study hospital are documented in the patient‟s electronic
medical record (EMR). One difficulty was identified within this system. The Obstetrical unit
utilizes a separate electronic medical record, PeriBirth (formerly E & C), from the EMR utilized
throughout the rest of the medical center, CIS. This is due to the features available in PeriBirth
that are useful in documenting the course of pre-natal, delivery and post-partum care. The
PeriBirth and CIS systems do not have a direct interface, a common problem in the realm of
healthcare informatics. Although the data from PeriBirth and CIS are accessible to personnel all
through the hospital, they must be accessed separately. The practical implication is that a postpartum Tdap immunization would need to be entered into each database. Both systems are in
keeping with the federal guidelines for compliance capturing the date the dose was administered,
the person and credentials of the vaccine administrator, the lot number and expiration date of the
vaccine, the dosage, site and route of administration, the date the Vaccine Information Statement
(VIS) was provided and the publication date of the VIS. The electronic systems have an on-line
history at the facility of about three years; formerly the hospital kept paper records which are
maintained for a period of at least thirty years, as mandated by law. Thus if a patient recently
received a Tdap immunization in the emergency room at this site, the documentation would have
been recorded and accessible to staff of the Women‟s Unit (Dr. John Santoro personal
communication, February 1, 2010).
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Standards also delineate the qualifications for vaccine administration. This is perhaps the
easiest to abide by within the hospital setting as only registered nurses (RNs) or licensed
practical nurses (LPNs) may administer medications. Unlike the office setting where medical
assistants may administer under a physician‟s license, only professional personnel act in this
capacity within the acute care setting. In this hospital, certain vaccines are maintained on the
nursing unit as stock for administration, such as influenza vaccine. Other vaccines that are used
less frequently are maintained in the pharmacy and delivered to the nursing unit within about 2
hours of ordering the biologic. Nursing and pharmacy staffs at this facility agree that with
respect to Tdap administration, it would be appropriate to stock the vaccine on the maternity
nursing units .
The need for treatment of potential adverse events is also facilitated by the hospital
environment due to the proximity to multiple personnel and equipment that may not be available
in non-hospital sites. In the project hospital, as in most hospitals, each patient unit is equipped
with a “crash cart” with resuscitation equipment and medications to treat anaphylaxis; nursing
personnel are trained in CPR and there are a multitude of disciplines providing for rapid response
to emergency events („codes‟): respiratory therapists, anesthesiologists, IV therapists, lab
personnel as well as nursing and resident physicians. The study site meets all of the standards
relating to providing immunizations in non-traditional settings (i.e. hospitals). This represents a
major facilitating factor to implementing Tdap standing order in this medical center.
National and State statistics
Data collection for this program evaluation included reviewing published national and
state statistics for Tdap immunization coverage from the National Immunization Survey (NIS),
the Behavioral Risk Factor Surveillance Survey (BRFSS), MDPH Immunization Program
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Summary of Immunization Level (i.e. schools and colleges) Surveys, National Health Interview
Survey (NHIS), and Massachusetts birth hospital survey findings.
Data identified from both the National Immunization Survey and the Behavioral Risk
Factor Survey has demonstrated disparities in uptake or coverage of the Tdap vaccine.
Adolescent uptake has increased over time and continues to improve across the Commonwealth.
The proportion of teens, aged 13 to 17, immunized with one dose of Tdap vaccine increased
from 30.4% to 40.8% from 2007 to 2008 (CDC, 2008b). The Massachusetts Department of
Public Health found that of the 81% of eligible children receiving a tetanus booster required for
entry into 7th grade, 60% of adolescents Tdap vaccine (unpublished summary of school
immunization survey levels, 2008-2009 school year). Within the college-aged population,
coverage is much lower as evidenced in Table 7.
Table 7. MDPH Annual School and College Immunization Survey 2008-2009.

Level

Td

Tdap

All College age students

82.55%

6.48%

Undergraduate

82.82%

7.01%

Health Science students

87.46%

8.73%

Health Science Graduate

79.08%

2.96%

National Immunization Survey (NIS) data from 2007 reveals that uptake of the new Tdap
vaccines among all adults in the two years since licensure was slow, only 2.1% in all groups
(CDC, 2008b). At the current time, the gap in vaccine uptake appears to be greatest within older
adolescent and adult cohorts.
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In the study hospital, currently there is no system in place to assess Tdap coverage. One
of the program recommendations is for the hospital and its‟ associated women‟s clinic to begin
routine assessment and documentation of Tdap immunization of all women.
Financial Considerations
The study hospital reports approximately 4,000 – 4,300 births annually over the last few
years as shown in Table 6.
Table 6. Annual births reported at the Project Hospital..
Year

Deliveries

2007

4,323

2008

4,180

2009

4,253

The area sees a high percentage of births in the adolescent age group. Springfield has
been reported to have the second highest teen birth rate in the Commonwealth according to a
MDPH report on Massachusetts births 2007 at 84.3/1.000 (MDPH, 2009). This figure is close to
four times the state rate of 22/1,000 births. Teen births account for roughly one-third of the
overall number of deliveries at the study site (Molly Gray RN MSN, personal communication,
February 19, 2010) and as previously mentioned, waning pertussis immunity represents a
potential threat for transmission to infants.
Massachusetts surveillance data has found the incidence rate of pertussis per 100,000
persons was highest in the age group less than one year of age. In 2007, the incidence rate was
103.8 and in 2008 it was 66.7. The overall incidence for all age groups in those two years was
18.8 and 12.1, respectively (N. Corcoros, personal communication, January 12, 2010). Since the
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beginning of the evaluation project, two infant cases of pertussis were identified in children who
were born in the hospital under study.
Eleven sites responding to DPH during the course of a recent policy analysis had a
procedure in place for post-partum Tdap administration. Each of these sites was contacted for an
interview to ascertain whether the facility had developed a written policy for vaccine
administration and the format of the protocol - either a generalized standing order or a physician
directed order. Six sites truly had a procedure in place, although none had yet developed a
written policy for administration. The other five sites were actually still in the process of
developing Tdap orders.
When queried about the issue of financial reimbursement with the facilities already
promoting Tdap vaccine, each of the hospitals indicated that there have been no financial
repercussions following the implementation of the new policy. Several organizations mentioned
that promoting a Tdap policy was in keeping with the mission of the hospital to provide the best
care for the mother. One maternity unit nurse manager remarked to me, “It is essentially the
right thing to do”.
One potential cost of an indeterminate nature is that of possible litigation if a facility was
to be found negligent in not providing the standard of care. During the course of the program
evaluation, two babies born at the study hospital were identified as having contracted pertussis.
While the aspect of potential liability was raised, it was not a main focus of the financial
considerations.
The provision of vaccine by the Massachusetts Department of Public Health to providers
who serve adolescent populations will have a financial impact on the Tdap program at the project
hospital. There currently is no corresponding program providing vaccine comprehensively to
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adults as does the federal entitlement Vaccines for Children (VFC) funding. MDPH‟s Childhood
Vaccine Availability Table (effective November 1, 2009, attached) affirms that Tdap vaccine is
provided for all children through eighteen years of age, regardless of insurance status,
particularly:


Adolescents at 7th grade entry (11 - 12 years of age).



Catch-up immunization of all 13 - 18 year olds.



Children 10 - 18 years of age who have been exposed to pertussis or in an outbreak
setting.

Catch up immunization of all thirteen to eighteen year olds would include young women
falling into that age category who present for delivery at the hospital under study. Provision of
state supplied (“free”) Tdap vaccine doses to mothers who are under nineteen years of age would
effectively reduce the overall number of doses that would need to be purchased in order to
implement Tdap immunization in the birthing unit by approximately one third.
Health Plan survey
In an unpublished survey of some of the major third party payers for healthcare in
Massachusetts, approximately fifteen major carriers provided feedback on Tdap coverage. All
insurance carriers indicated that their plans provided for reimbursement for the cost of Tdap
vaccine as well as administration costs associated with vaccination to their participants.
Information on the specific amount of reimbursement provided by each company was considered
proprietary between carriers and their contracted providers. The attached chart in Appendix H
shows a compilation of responses to questions regarding reimbursement settings. All of the
respondents indicated that Tdap immunization would be covered in the birth setting. There
appeared to be some conflict in responses to whether the plan included reimbursement for Tdap
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as part of the global reimbursement fee for delivery and its coverage in the birth setting. Further
follow up was necessary to determine the specifics of coverage. Eight health plans indicated that
it is not currently included; six indicated that it is included and one responded “maybe”
(indicating that Tdap is included for payment by that carrier, if the particular birth hospital is a
contracted provider with that company).
What does this mean in financial terms for instituting a Tdap immunization program at
this hospital site? There are two potential implications. The first is related to providers who do
not include Tdap as part of the reimbursement. The Managed Care Accounts department could
undertake discussions negotiating remuneration with those carriers originating from institution of
an added service - Tdap vaccination. This added service would be based upon Standard of Care
recommendations published by recognized authorities and professional organizations (i.e.
Advisory Committee on Immunization Practices, American Congress of Obstetricians and
Gynecologists, formerly American College). The second implication relates to providers who do
currently include Tdap as part of the global delivery fee. Similarly, remuneration would have to
be re-negotiated with each carrier based upon the establishment of a new service to the spectrum
of care normally provided during delivery thereby increasing the cost per delivery. Some
carriers who responded to whether Tdap vaccine would be covered in the birth setting as “no”
Tdap was not included as part of the reimbursement schedule for delivery were contacted for
clarification of their answers. Several carriers indicated that Tdap would be a covered expense;
however it would have to be billed separately.
There is also pending legislation that would greatly aid in implementing the standard of
care for Tdap immunization in the birth setting. Two Senate bills, S859 and S470, and one
House bill, H3453 would provide for “first dollar coverage” of vaccine purchases and 100% of
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the reasonable and customary charges for associated with administration of vaccines in all health
care setting and provide funding for a statewide immunization registry. Senate bill 859, drafted
by Senator Richard Moore was referred to the Joint Committee on Public Health in January of
‟09, the House concurred and a hearing was held in September of 2009. Ms. Fargo‟s Senate bill
470 was referred out of the Senate, with the House concurring, to the Joint Committee on
Financial Services. The bill presented by Alice Wolf in January of 2009, House 3453, was
referred to the Joint Committee on Health Care Financing, with the Senate concurring. I met
with State Representative John Scibak in mid-February and learned that these three bills were
recently reported favorably and redrafted into Senate bill 2195 which is now in the Senate Ways
and Means Committee (John Scibak, personal communication, February 15, 2009). This
legislation would alleviate the financial burden on hospitals in implementing the Tdap standard
of care at birth. State employees are prohibited from lobbying on behalf of legislation; however
the information about these proposals was made available to the team at the medical center so
that their appropriate professional organizations (and/or individuals) could assist with legislative
efforts by advocating for favorable consideration of anticipated laws.
Overall, the cost of instituting Tdap immunization in the post-partum setting was perhaps
the most difficult one to ascertain and would essentially require lengthy and on-going financial
analysis by the institution. It was challenging to try to obtain precise information for the program
evaluation in terms of cost analysis. Conducting the health plan survey dealt with generalizable
answers rather than specific responses related to patients for this hospital. The medical center
also did not afford access to explicit details in terms of the numbers of patients covered by
various third party payers delivering within their facility. Ultimately, final recommendations to
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the organization incorporated a suggestion for the Pharmacy Department to work closely with
Managed Care Accounts to delineate the incremental impact on operations.
External Reaction Panel
The use of an External Reaction Panel was a unique feature of the program evaluation.
This feature was utilized by the AACN Task Force charged with examining the clinical doctorate
or practice doctorate program. The strategy was embraced and applied to this capstone project,
interviewing professionals outside of project facility inviting comments, perspectives, soliciting
resources and insights, especially as my project related to an evaluation to determine feasibility
for a new program. My panel consisted of 10 individuals with varying areas of expertise listed in
Appendix J, representing a wide array of perspectives and disciplines. The dialogues with expert
panel members afforded valuable perspectives.
In the consultation with the public health physician, she emphasized the fact that
providing Tdap vaccine to susceptible women in the post-partum period is a standard of care as
much as providing hepatitis B post-exposure prophylaxis to high risk infants born to HBsAg+
women. The maternity unit nurse manager of a competing hospital facility was able to outline the
rationale for their institution to begin offering Tdap to new mothers and also to demonstrate the
ordering system and the manner in which vaccine is provided to the maternity unit for ready
access and ease of administration at a time prior to discharge. The nurse recounted that through
the educational efforts of nurses throughout the family life center, an estimated 85% of patients
availed themselves of the opportunity to become immunized. She also related the cultural issues
involved for a number of their foreign born clients. Patients who immigrated to the United
States from Russia, Somalia and some other locales are distrustful of immunization and eschew
vaccination if it is not “required” by the government.
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Two nurses provided practical perspectives related to the project. The first, a nurse
educator in the National Immunization Program at CDC was able to provide contacts with
hospitals in other states who have undertaken Tdap vaccine programs. Upon contacting those
programs, it was noted that a number of them were grant funded from institutions like the Robert
Wood Johnson Foundation. The funding issues were essentially the same as here in the
Commonwealth, adult immunization programs lack a comprehensive source of funding similar to
childhood programs and as a result must rely on a mixture of funding sources. Another insight
gleaned from the out-of-state contacts is that most programs instituted vaccination programs first
and wrote policies secondarily – if at all. Seemingly, “form followed function”. The second
nurse, a clinical practice manager who was relatively new to office practice but with a long
history of acute care experience was disturbed by what she saw as a lack of standardization
among providers in office settings and among organizationally related office practices.
Approximately two years ago, she set about to institute standard practices by developing an
immunization manual for all project hospital-related offices which integrated immunization
standing orders for all vaccines, including Tdap for adults. The response by providers has been
overwhelmingly favorable.
Two interviews were conducted to gain perspectives on changing practice; both
recounted the difficulties encountered in health care when practice changes are identified as
being necessary. The nurse educator recounted stories about student projects involving examples
of change in practice, change in knowledge and change in theory. She related her absolute belief
in the power of nursing to connect with community needs and the value of nursing leadership in
guiding and influencing change. She stated that linking actions to theory, operationalizing
guidelines in a creative and assertive manner are keys to addressing gaps in practice and to multi-
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disciplinary collaboration. A colleague in the DNP program described those same aspects of
change required in her oral health Capstone project. Her project incorporated changes required in
knowledge, addressed changes in the attitude of providers and the public, and necessitated
changes in practice. She recommended an interesting book entitled the Policy Paradox (Stone,
2002) that highlights the issues of equity, efficiency, liberty, and security when advocating
policy change. The topics of equity and efficiency were especially pertinent to this program
evaluation.
I attended two presentations by colleagues at the Department of Public Health on
initiatives for decreasing Hospital Acquired Infections (HAIs) and Serious Reportable Events
(SREs). The focus on HAIs originated all the way back to the 1960s as a result of a
staphylococcus aureus pandemic in the 1950s. It was interesting to note how often public health
initiatives only result from profound events that are perceived to be serious enough to demand
change in practice. Her presentation provided documentation of the decreasing crude death rate
from infectious disease and the effects of changes in 21st century technology. The technology
issue is especially pertinent to the topic of pertussis. Through laboratory analysis, research has
been able to document the prevalence of waning immunity in previously immunized populations.
Breakthroughs in vaccine manufacturing have capitalized on new technologies in the production
of biologics to produce an acellular formulation of pertussis vaccine, one that is safe and
effective for adults and produces minimal side effects. The second presentation highlighted the
definition by the National Quality Forum (NQF) of hospital-associated adverse medical events
divided into six major categories: surgical related events, product or device related events,
environmental events, criminal events, and patient protection related events and care
management related events. These last two categories are conceivably where hospital Tdap
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initiatives might fall. The talk also stressed the importance of the topic within the scope of the
national health care reform debate vis a vis reporting requirements enacted by individual states
and federal and state regulations for reimbursement by health insurance carriers. Both
presentations reaffirmed the shifting vantage point with respect to preventable medical problems
and the national scope to raise awareness, promote transparency and motivate healthcare
facilities to prioritize infection prevention. All of these factors could be linked to protection of
infants through the promotion of pertussis protection of the mother.
Perhaps the most interesting discussion I had was with Commander Linder, USAF in
talking about Cockpit Resource Management (CRM) initiative. Commander Linder who is a 27
year pilot recounted the atmosphere in flying 25 years ago where the Captain was akin to a God
(perhaps similar to the era where the physician was like a God). Over the course of time, changes
have occurred that created an environment which allowed for respectful communication among
flight operations personnel that permitted to introduction of new or better information upon
which to base changes in practice. This very successful model of leadership has been widely
explored in recent years and touted as a methodology of improving performance in other sectors.
The external reaction panel served as a focus group to give me feedback and new
direction to the program evaluation. It was a valuable learning tool and extremely informative
during the program evaluation.
Justifying conclusions/ Changing
Standards reflect the value held by stakeholders (CDC, 1999). As previously cited, the
hospital‟s mission is to improve the health of the people in communities every day, with quality
and compassion. The consensus of the program evaluation was that instituting an immunization
order for Tdap “is the right thing to do”. The analysis and synthesis of information collected
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demonstrated that the medical center may incur some costs especially at the beginning of the
program. The values held by the participants assisted in deciding for immunization in keeping
with the standard of care for which the hospital strives and would serve as a method of
collaboration with other agencies in the larger public health fight against pertussis. Interpretation
of the health plan survey showed itself as a forum for negotiating reimbursement for Tdap
vaccine from plans not currently providing coverage and potential for re-negotiating increased
reimbursement from plans already providing coverage for the immunization. Participants felt the
worth of a Tdap immunization program to be almost immeasurable in terms of the immediate
post-partum delivery period presenting a window of opportunity and the optimal time to
immunize susceptible women and representing a significant chance for impacting the health of
newborn infants.
The recommendation for implementing Tdap orders post-delivery also demonstrates a
commitment to social equity in that all women would be afforded a chance to become
immunized and protect their babies, not just the ones who have primary care physicians that
choose to stock and administer adult vaccines. As of April 1st, an electronic prompt appeared in
the electronic medical record (EMR) once a mother is identified as having delivered. The
prompt reminds the provider about ordering Tdap vaccine for the newly delivered woman. The
plan is to estimate the impact of the electronic reminder after a pilot period of two weeks before
implementing a full standing order in the care set for post-partum women.
Ensuring use and sharing lessons learned/ Refreezing
Interviews with facility personnel identified educational needs for providers, residents,
nursing staff, and for patients. While many of the obstetrical staff members were in favor of the
idea of standing orders for pertussis, a few felt that pertussis was not a pressing enough issue to
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warrant the effort or expense during a hectic hospital stay for the new mom and a demanding
schedule for the nurses. Some providers were unaware of the requirements for documentation
relating to vaccine administration, specifically the need for a signature of the patient or
provisions for informed consent. It was suggested that a Grand Rounds presentation for providers
in the obstetrical and pediatric units could help to address these concerns. An educational
presentation was made in February for nurse midwives and another session is scheduled in April
for Obstetrical Residents. These seminars review the epidemiology of pertussis, national
guidelines for the standard of care relating to Tdap immunization, federal and state requirement
for the „duty to warn‟, documentation and the impact of a provider orders. Presentations will be
made to the nursing staff to review the licensure properties of Tdap, administration
recommendations, documentation and MA Board of Registration in nursing provisions and to the
Women‟s clinic staff emphasizing the need for promoting pre-conception immunization and
documenting immunization coverage prior to delivery. All groups will be advised on the
paramount importance of assessing Tdap coverage in all settings and the tremendous impact that
professional advocacy for Tdap vaccination will contribute to the success of the initiative.
Program Evaluation Recommendations
Specific recommendations for project site
It was recommended that the medical center consider the application of “Sutton‟s Law”
to the issue of instituting Tdap standing orders for new mothers in the birth setting. The famous
bank robber, Willie Sutton, when asked why he robbed banks, was purported to have answered,
“Because that's where the money is”. In Massachusetts, it is documented that 97% of all births
take place in a birthing facility. In terms of assessing the optimal point of impact for Tdap

Standing Orders for Tdap Immunization

47

immunization of new mothers, the obvious answer is the birthing unit, “because that‟s where the
mothers are!”
The formal recommendations to the hospital were to:


Institute assessment for Tdap coverage for pregnant women as part of prenatal
screening, recommending post-partum immunization for susceptible women along
with recommending immunization to the father of the baby, siblings, grandparents
and care givers in order to deploy the „cocooning‟ strategy.



Develop a program for Tdap immunization before discharge via standing orders as
provided for by BORN ruling or a care set for individual providers to choose Tdap
vaccine from a list of prescribed orders.



Develop documents for screening patients before immunization for nursing staff to
undertake proper assessment of indications and contraindications for vaccination
utilizing the Tdap VIS form.



Undertake educational programs for stakeholders: obstetricians and pediatricians,
residents, nurse midwives, nursing staff, mothers and families.

The hospital was encouraged to utilize the resources available to them from the
Department of Public Health in the form of state-supplied (free vaccine) supported with federal
VFC funds. Strong collaborations were developed between DPH and the birthing facilities
throughout the pandemic response in the fall, the Tdap initiative could capitalize on those
partnerships.
A recommendation was also made for personnel from the Pharmacy and Therapeutics
Committee and the Managed Care Accounting Department to further investigate the issue of
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third party payer reimbursement for a more representative cost analysis than the generic health
plan survey was able to offer.
In term of assessing the effects of an electronic reminder prompt, a physician directed
order or an institutional standing order, measurements should be made after a pilot period of two
weeks to ascertain any „glitches‟ in the system. After that initial period, measurements should be
taken after the first month (to assess whether a mid-course correction or alteration is required),
quarterly and after the first year. Table 7 shows a potential chart for collection of data.
Table 7. Tdap immunization data collection.
Pilot

1st

1st

2nd

3rd

4th

Period month quarter quarter quarter quarter
Number of overall deliveries
Number of susceptibles (minus
women previously immunized
with Tdap vaccine)
Number of ineligibles (medical
contraindications, religious or
philosophical declinations,
refusals)
Number of women immunized

These recommendations would enhance services already in place at the facility to
improve the health of patients across the region. Accordingly, this medical center has previously
been recognized by a myriad of organizations such as the National Benchmarks for Success‟
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recognition as one of the Top Ten Teaching Hospitals in the Nation, the 2006 Premier Award for
Quality, the recent affirmation of Magnet Hospital for Nursing designation, and the Foster
McGraw Prize for Excellence in Community Service. Among the lobby display of awards is one
from the American Hospital Association awarded for “leadership in meeting health care needs of
the community and commitment to mutual goal of increasing quality health care and health
services for all people”. Implementing Tdap immunization for new mothers in the birthing unit
furthers the mission of the center to improve the health of the people in the communities of the
area.
One of the three legs of public health practice (assessment, policy development, and
assurance) is demonstrated through the proposed amendments to the school entry regulations. In
the fall of 2011, seventh grade and college students will be required to have a dose of Tdap
vaccine. This regulation will update the requirement for Td boosters in preference of a pertussiscontaining vaccine. Although it will take many years, over time, as more class cohorts fall under
the requirement and as Tdap vaccine enjoys further distribution and a wider uptake, the overall
financial impact of providing Tdap vaccine to susceptible women in the hospital setting will
lessen as the gap in vaccine coverage shrinks.
The Strengths and Weaknesses of the Evaluation
The strengths and weaknesses of program evaluation were reflected against the Standards
for Evaluation in Appendix I. Establishing a hospital-based Tdap immunization program would
provide peace of mind to the new mother until the infant reaches the recommended age for DTaP
immunization as well as providing immunity to susceptible women. This evaluation ultimately
recommended that the obstetrical management of the project hospital expand immunization
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services, to include Tetanus- Diphtheria- and acellular Pertussis (Tdap) vaccines – in the birth
setting.
First, the collaborative effort in this evaluation was paramount. The program evaluation
benefited from the use of resources of the Department of Public Health and networking that was
invaluable to moving the process along. Several individuals and organizations not affiliated with
the institution were solicited for advice, comments, and feedback. Members of the project team
remarked that there had been a long standing desire “to do something about Tdap”; unfortunately
none of the hospital personnel had the time to devote to the project, so it was advantageous to
have one person dedicated to the topic. It was a team effort and the commitment of certain
employees of the facility was evident. Initially there were a couple of stakeholders who
expressed opinions of “There are so many vaccines now!” and “Why should I be worried about
pertussis?” These two people were in the minority however as the sentiment for the project was
overwhelmingly in favor of the idea.
Weaknesses involved in the evaluation also arose from not being an employee of the
institution. Not being intimately familiar with the organizational hierarchy and the “politics” that
permeates every organization was a disadvantage. Positioned as an „outsider‟ also affected
access to information and affected the timeline in that as a guest of the facility, it took somewhat
longer to arrange interviews and meetings than had I been working within the facility, although
as an employee, perhaps I, too, would not have had the time to commit to the undertaking. It
was difficult to go into a nationally recognized facility and make observations that resulted in
recommendations for change. An important facet of the evaluation was how others would react
to the findings. The wording and delivery of recommendations had to be made respectfully and
without judgmental overtones. It was essential that the stakeholders feel an integral part in the
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evaluation process and that the resulting outcome was a positive experience, seen as one that
would move the organization forward in implementing a new standard of care for mothers. It
was also necessary from the outset that all parties understand that the task was a student
Capstone project rather than a formal requirement by the State Health Department.
One issue that was difficult to ascertain was that of the actual incidence of infant
pertussis cases related to the overall number of births at this site. The MDPH policy is to report
infectious disease data in the aggregate. Confidentiality prohibits release of data for community
populations of less than 50,000 people if cell sizes contain numbers of five or fewer cases.
Therefore, we were unable to obtain data on pertussis cases that may have been born in the
facility but actually resided in the multitude of communities in the surrounding area with
populations less than the reporting threshold. Additionally, the facility itself would be unaware
of pertussis cases associated with births in the medical center. Pediatric providers or family
practitioners are required to report communicable disease findings to the state not to the birthing
facility.
Another issue pertinent to program evaluation in general and this project in particular is
the time factor involved. An ambitious timeline was set out that was ultimately affected by
history – events outside the program affecting the project and those involved. The advent of the
first influenza pandemic in more than forty years had both beneficial and detrimental effects.
Surveillance data demonstrating that transmission of the novel virus strain was highest in
younger populations and that complications were inordinately affecting pregnant women lead to
ACIP recommendations for pregnant and post-partum women to be included in the first priority
group for immunization once H1N1 vaccine became available. All other activities in public
health agencies and acute care facilities seemed to take a back seat to the urgent need to
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immunize the population against the new virus, thus the timeline for the program evaluation
became prolonged. The pandemic produced a favorable though perhaps unintended outcome.
Precisely because pregnant women were affected by influenza morbidity and mortality, new
attention was focused on the safety of immunizing women during the perinatal period; this will
help to raise the awareness of both the need to assess risk factors in this cohort and the ability to
use the opportunity to immunize susceptible women. This may have a favorable effect on Tdap
immunization programs in the future.
The issue of maturation will ultimately lessen the overall need for the program. At the
present time, the lack of school requirements for Tdap and deficiencies in vaccination services
for adults point to post-partum immunization as a way to address a gap in vaccine delivery
systems. Over time, the implementation of school regulations at the 7th grade and college levels
as well as requirements for Tdap vaccination among health care students will result in higher
population coverage with the vaccine. High immunization rates will decrease the urgency for inhospital Tdap immunization similar to the history of rubella vaccination. The need for assessing
and immunizing post-partum women will never disappear entirely however due to varying
school regulations among the fifty states and the number of women giving birth who hail from
countries other than the United States where vaccination services are not readily available.
While most personnel agreed theoretically that the pertussis is an awful disease and one
worthy of prevention in all age groups, especially infants, the project outcome essentially meant
more work for the nurses. This is where utilizing change theory became important to the
educational process, especially in promoting the ethics of the change and the climate for
evidenced based practice – essentially the public health nursing leadership required to improve
the standard of care for all delivering mothers.
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The elements of program evaluation were carried out in a professional and ethical manner
on the basis of dialogue, observation and reflection. Clear and accurate documentation of the
program under evaluation was attempted with sufficient detail to provide context and possible
influences on the program. Sources of information provided sound statistics for valid and
reliable conclusions. One drawback that was encountered was the lack of access to proprietary
information. The evaluator was not privy to contractual agreements for bulk purchase pricing
between the hospital and GSK. Another area of confidentiality was that of the global fees
negotiated for deliveries between health care plans and the medical center and the actual figures
of patients delivering attributed to each insurance carrier. Thus only generalizations were made
in terms of analysis rather than true cost estimates. Bias on the part of the evaluator in favor of
immunization may not be shared by others, who may reach different conclusions.
Future Steps
The Tdap project is in the process of seeking resources to educate mothers and families
on the need for Tdap. Particular items that are being investigated are: parent newsletter articles, a
bassinette informational card, patient instructional videos or DVD‟s for the patient education TV
channel and adult immunization cards for newly immunized mothers. A local college nursing
student has expressed interest in working with the hospital on developing an informational card
for the newborn bassinet on pertussis and the importance of immunizing the baby‟s family and
care givers as part of an honor project. A group of high school students has in interest in
developing a short patient teaching video on pertussis and Tdap vaccination.
The pharmacy department deals with contracting and purchasing of pharmaceuticals and
vaccine biologics. Plans for the Tdap initiative in the hospital have been identified through the
supply chain via the vaccine company representative. Linking the pharmacy protocol with
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communication to the distribution sites was an important part of ensuring sufficient vaccine
supplies for the project and ensuring stability of the inventory over time according the vaccine
purchaser. The effect of this communication pathway forestalls any delays in ordering or
obtaining vaccine resulting from what might appear to be an inordinate use of vaccine based on
historic usage and purchase arrangements. Future meetings will be held between the nursing
administration, the pharmacy department, and the Department of Public Health regarding the
hospital‟s enrollment with the state health program and the receipt of state supplied vaccines.
The hallmark of public health is collaboration, characterized by the formation of
partnerships to address public health problems. The issue of pertussis transmission is being
tackled on the state level by direct and indirect means. The Massachusetts Department of Public
Health has cooperated with the executive branch and the state legislature to develop amendments
to school entry regulations in Massachusetts that would provide for a Tdap immunization
requirement at entry into 7th grade and for college matriculation. This regulation is in the
process of promulgation and is expected to be finalized for the start of the 2011 school year.
In November of 2009, MDPH distributed a recommendation for Tdap vaccine, in
preference over Td vaccine, for adolescents in all provider settings. The advisory notified all
recipients as to the availability of state supplied Tdap vaccine for adolescents 10 – 18 years of
age to all health care facilities and to emergency rooms and urgent care settings.
In January of 2010, MDPH distributed a notice of time-limited availability of state
supplied Tdap vaccine (as well as HPV, varicella, and zoster vaccine) for all adults 10 -26 years
of age seen at public sites. Public sites in Massachusetts are defined as community health
centers and local health departments. Hepatitis A and B, MMR and pneumococcal vaccines are
already available to these sites through normal ordering channels. The addition of Tdap and
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other biologics is being made available until June 2010 and is possible through the use of
American Recovery and Reinvestment Act (ARRA) funds.
Implications for Nursing
This program evaluation of the current practices and readiness for implementation of
Tdap orders for immunization in a birthing hospital illustrates the problem identified by the
Institute of Medicine (IOM) report on the state of health care delivery (Institute of Medicine,
2001). The report emphasized fragmentation of care, including the dilemma of undertaking a
financial burden for a new service, as barriers for hospitals in adopting change.
In keeping with the promotion of health care that is “safe, effective, client-centered,
timely efficient, and equitable, employing a new setting (the hospital) to provide immunization
services rests on the scientific underpinnings of the ACIP statement for pertussis protection
(CDC, 2000, p.6). It utilizes organizational skills – the ability to conceptualize new care delivery
models, and systems thinking – navigating the policy and quality improvement arenas. One
aspect of advanced nursing practice is advocacy for health care policy – designing, influencing
and implementing health care policies that frame access, addresses social justice and equity,
quality, efficacy, and regulation of practice.
This project designing an evidence based intervention demonstrates the translation of
research (conducted by the ACIP) into safe and effective policy. A policy for hospital based
Tdap vaccination is an example of nursing leadership aimed at institutionalizing one very
specific clinical preventive and population health service for susceptible individuals that will
have an ultimate impact on aggregates (inducement of community or herd immunity) and
vulnerable populations (newborn infants). This project is a synthesis of academic work at the
University of Massachusetts including elements of practice change initiatives. In short, the
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project summarizes my growth in knowledge and expertise and serves as the foundation for
future scholarly practice within the Department of Public Health related to plans for pertussis
prevention, response and surveillance.
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Appendix A

Standard of Care
Tdap immunization of susceptible mothers in birth setting

Centers for Disease Control (2008a) Advisory Committee on Immunization Practices (ACIP)
CDC's Advisory Committee on Immunization Practices recommends that pregnant
women who were not vaccinated previously with Tdap: receive Tdap in the immediate
postpartum period before discharge from hospital or birthing center.

American Congress of Obstetricians and Gynecologists (formerly American College) ACOG
Committee Opinion 438 (replaces 282, January 2003)
The ACIP recommendations for pertussis, tetanus, and diphtheria vaccination have been
revised to include routine post-partum Tdap administration if the woman has not had Tdap in the
past. The Committee on Obstetric Practice supports these recommendations:
To add protection against pertussis, Td vaccination during pregnancy can be
deferred and Tdap vaccination given before postpartum discharge from the hospital in women
who are likely to have sufficient tetanus and diphtheria protection until delivery, who have not
previously received Tdap and in whom it has been 2 years or more since the most recent Td.
Having standing orders at the hospital can help facilitate this. If Tdap cannot be administered at
or before discharge, the woman should receive the dose as soon as possible thereafter.

American College of Nurse Midwives – Share With Women Tetanus, diphtheria, and pertussis (Td or Tdap): Adults who have not had these
vaccines in childhood or have not had a booster in 10 years. Those with an injury and no booster
in 5 years. Those with no booster with pertussis. For postpartum women with no recent
vaccination, healthcare workers, and persons around infants to age 12 months. (An initial series
plus regular boosters.)

Standing Orders for Tdap Immunization

64

Appendix B
Massachusetts Board of Registration in Nursing Advisory Ruling
Title: Administration of Immunizing Agents or Vaccines
Advisory Ruling Number: 9804
Authority:
The Massachusetts Board of Registration in Nursing (Board) issues this Advisory Ruling on Nursing
practice pursuant to Massachusetts General Laws ("G.L."), chapter 30A, section 8 and chapter 112,
section 80B.
Date Issued: May 13, 1998
Date Revised:May 2002, March 14, 2007
Scope of Practice: Registered Nurse and Licensed Practical Nurse
Purpose: To guide the practice of the Registered Nurse and Licensed Practical Nurse ("the nurse") who
as part of their nursing practice may administer immunizing agents or vaccines to any member of the
public in any and all settings. Such practice must be in compliance "G.L." c. 112, s. 80B, 244 CMR 3.02:
Responsibility and Functions - Registered Nurse; 244 CMR 3.04: Responsibilities and Functions Practical Nurse; 244 CMR 9.03 (8): Identification Badge; 244 CMR 9.03 (9): Responsibility and
Accountability; 244 CMR 9.03 (10): Acts within Scope of Practice; 244 CMR 9.03 (11): Performance of
Techniques and Procedures; 244 CMR 9.03 (12): Competency; and 244 CMR 9.03 (44):
Documentation.
Advisory: Immunizing agents or vaccines may be administered only under the following provisions. The
nurse must:
 Verify the orders from a duly authorized prescriber. A nurse may administer an immunizing agent
or vaccine ordered from a Standing Order Protocol. A standing order protocol must include:
o The name(s) of the immunizing agent or vaccine to be administered;
o The dose to be administered;
o The route or method of administration;
o Inclusion/Exclusion criteria that the nurse will assess for before administering the
immunizing agent or vaccine; and
o The signature or approval by a duly authorized prescriber either directly on the standing
order or on file with the facility/agency/program providing individual or mass immunization
or vaccinations;
 Be properly educated in the:
o Storage, handling, administration, contraindications, reporting of adverse effects, and
documentation of the immunizing agent or vaccine;
 Complete accurate and legible entries in all records required by federal and state law;
 Provide education to the client/patient/resident of the immunizing agent or vaccine on the risks
and benefits of accepting or refusing the opportunity to receive the immunizing agent or
vaccine;
 Document a process of informed consent with the client/patient/resident of the immunizing agent
or vaccine that is reflective of the educational materials provided;
 Complete an assessment including an allergy history of the client/patient/resident of the
immunizing agent or vaccine prior to the administration of an immunizing agent or vaccine;
 Know where, and how to access and use emergency devices, techniques and services for adverse
reactions; and
 Obtain parental permission in the case of administration to children in compliance with local,
state and federal requirements.
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CDC Grantee Guide to Immunization Program Evaluation
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Appendix D

Medical Center Logic Model
New mothers Tdap Immunization Program
Inputs
• OB, CNM staff
• Resident & Nsg. Staff
• Pharmacy staff
•MDPH technical advice
• GSK Vaccine Rep.
•Educational materials:
bassinet cards, parent
newsletters
• Vaccine Information
Statements
• DVD for patient TV educ.
•Vaccine training program
•Immunization screening tool
•Immunization standing
orders
Surveillance
Assessment
Strategic Plan/Program
Review of the Literature
Prof. Recommendations
Guidance Documents

Activities

Outputs

Short Term

Expand Tdap
Immunization capacity

# CNMs
In-serviced

Establish Tdap
vaccine
capacity

Staff receive
Tdap Immunization
In-Service

# nursing staff
In-serviced on Tdap
service delivery

Immunization
screening
Client pertussis
Education &
Awareness - VIS
Tdap Immunization

# resident physicians
- educational
session

Increase
communication
on
pertussis disease
between providers
& clients

# of patients
Screened
# Contraindications/
Refusals

Institute
Tdap

# of clients
immunized

Standing Order
Screening &
Vaccination
on LDRP unit

Grand Rounds

Evaluation Methodologies and Outcomes

Intermediate
Term
Tdap
Policies
& practices
Adopted

Long
Term

Goal:
Increase
Herd Immunity

Increase
Tdap
doses
Reduce
Reservoir for
pertussis
Transmission
Provide
Protection
To
Vulnerable
infants

Reduce
Incidence of
pertussis

Standing Orders for Tdap Immunization
Appendix E

National Vaccine Advisory Committee
Standards for Conducting Adult Immunization Programs in Nontraditional
Settings
Standard 1

Information and Education for Vaccinees

Standard 2

Vaccine Storage and Handling

Standard 3

Immunization History

Standard 4

Contraindications

Standard 5

Record Keeping

Standard 6

Vaccine Administration

Standard 7

Adverse Events

Adapted from CDC MMWR 2000, March, 24 49:1-29.
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Reimburse
Cost of
Tdap
vaccine

Reimburse
administration
costs

What %
of HP
customers
have
costs of
Tdap &
adm.
covered
for
newborn
mothers?

OB/GYN

Academic

Birthing facility

All settings
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Appendix G

[Unidentified] health plan*

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Yes

No

No

BCBSMA

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Yes

No

No

BCBSRI

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Yes

Yes

BMC Health Net

Yes

Yes

100%

No

Yes

Yes

Yes

No

Yes

Cigna Healthcare of MA

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Yes

Yes

Fallon Community Health
Plan

Yes

Yes

100%

Yes

Yes

Yes

Yes

Yes

No

Harvard Pilgrim Healthcare

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Maybe

Health New England

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Yes

No

No

MassHealth PCC

Yes

Yes

>75%

Yes

Yes

No

No

MIT Medical Health Plan

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Neighborhood Health Plan

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Network Health

Yes

Yes

>75%

Yes

Yes

Yes

Yes

Tufts Health Plan of NE

Yes

Yes

>75%

Yes

Yes

Yes

Unicare

Yes

Yes

>75%

Yes

Yes

United Health Care of NE

Yes

Yes

>75%

Yes

Yes

Appendix G
Health Plan

In which settings is Tdap administration covered?

Yes
Yes
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Does the plan
currently
Include Tdap
as part of the
global
Reimbursement
Fee for
Deliver?

If currently
not
covering
are you
considering
including
Tdap
coverage
in the near
future?

No

Yes
No

Uncertain

Yes

No

No

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes
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Appendix H
Standards for Effective Evaluation
“The accuracy standards are intended to ensure that an evaluation will reveal and convey
technically adequate information about the features that determine worth or merit of the program
being evaluated”

Program

The program being evaluated should be described and documented

Documentation

clearly and accurately, so that the program is clearly identified.

Context Analysis

The context in which the program exists should be examined in enough
detail, so that its likely influences on the program can be identified

Described Purposes

The purposes and procedures of the evaluation should be monitored and

and Procedures

described in enough detail, so that they can be identified and assessed

Defensible

The sources of information used in a program evaluation should be

Information Sources

described in enough detail, so that the adequacy of the information can
be assessed

Valid Information

The information gathering procedures should be chosen or developed
and then implemented so that they will assure that the interpretation
arrived at is valid for the intended use

Reliable Information

The information gathering procedures should be chosen or developed
and then implemented so that they will assure that the information
obtained is sufficiently reliable for the intended use.

Systematic

The information collected, processed, and reported in an evaluation

Information

should be systematically reviewed and any errors found should be
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corrected
Analysis of

Quantitative information in an evaluation should be appropriately and

Quantitative

systematically analyzed so that evaluation questions are effectively

Information

answered

Analysis of

Qualitative information in an evaluation should be appropriately and

Qualitative

systematically analyzed so that evaluation questions are effectively

Information

answered

Justified Conclusions The conclusions reached in an evaluation should be explicitly justified,
so that stakeholders can assess them
Impartial Reporting

Reporting procedures should guard against the distortion caused by
personal feelings and biases of any party to the evaluation, so that
evaluation reports fairly reflect the evaluation findings. Reporting
procedures should guard against the distortion caused by personal
feelings and biases of any party to the evaluation, so that evaluation
reports fairly reflect the evaluation findings.

Meta-evaluation

The evaluation itself should be formatively and summatively evaluated
against these and other pertinent standards, so that its conduct is
appropriately guided and, on completion, stakeholders can closely
examine its strengths and weaknesses

72

Standing Orders for Tdap Immunization
Appendix I
My thanks to the External Reaction Panel:
Sharon Asher, RN, BSN – Practice Clinical Coordinator
John Crowley - GlaxoSmithKline, Immunization Account Manager
Elizabeth Daake, MPH – MDPH Director pf Policy Development & Planning
Lela Hobby-Burns, DNP-c, RN – University of Massachusetts SON
Susan M. Lett, MD, MPH – MDPH Medical Director, Immunization Program
Col. James Linder USAF – Commander 439th Operations Group Westover ARB
Claire Margosiak, RN, BSN – Mercy Medical Center, Director Family Life Center
Eileen McHale, RN, BSN – MDPH Betsy Lehman Center for Patient Safety
Rep. John Scibak – MA state representative, 2nd Hampshire district
Cheryl Sheils, EdD, RN – Elms College assistant professor of nursing
Donna Weaver RN, MSN – CDC National Immunization Program nurse educator
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Author‟s Note
Perseverance can be defined as diligence and determination. Those attributes brought me
to the culmination of the DNP program, this Capstone project. There is one piece of scripture
that characterizes my thoughts at this juncture.

Phillipians 4:13
I can do all things through Him who strengths me.

The love and support of my family, my son – Michael, my daughter - Meghan and my
anam cara – the friend of my soul, my husband Kevin have sustained me through the
extraordinary challenges of the program and over the last year. I thank you from the depths of
my heart.

My work is dedicated to my late mother, Eleanor McCurry Crean R.N. who since I first
announced at the age of six that I wanted to be a nurse, “just like my mother”, provided me the
foundation of caring upon which to base my practice.

Comments may be addressed to the author at: htaugher@admin.umass.edu

